| abstract |
The present disclosure provides methods for treating lupus nephritis in an individual with lupus. In some embodiments, the method comprises administering to the individual an effective amount of a type II anti-CD20 antibody. In other aspects, the present disclosure provides methods for treating membranous nephropathy. |